Digitalization of health care in low- and middle-income countries.

Journal: Bulletin of the World Health Organization
PMID:

Abstract

The rising incidence of noncommunicable diseases, combined with the costs of mitigating climate change, sovereign debt and regional conflicts, is undermining global health security and threatening progress towards achieving the sustainable development goals of the United Nations. The negative impact of these polycrises is disproportionately borne by low- and middle-income countries, which have the highest disease burden and lowest health-care spending. Health digitalization is emerging as a promising countermeasure, accelerated by artificial intelligence (AI) software and quantum computing hardware. We provide a multisector critical analysis of the three key enablers - governance, infrastructure and security - of the responsible AI-enabled digitalization for safe, affordable, equitable and sustainable health-care systems in low- and middle-income countries. We consider leading use cases in public-private partnerships, democratized sovereign AI and embedded human security. Our analysis proposes that these use cases demonstrate how digital AI-accelerated global health may be advanced as human-centred managed strategic competition. We conducted our analysis through an inclusive range of theoretical perspectives and practical experience spanning academia, industry and practice across the world. We provide recommendations for the responsible management of the key enablers to accelerate global health for all. We anticipate that this paper will be useful for public health decision-makers, both in low- and middle-income countries leading local health digitalization, and in high-income countries supporting this transaction through their technologies, funding and knowledge exchange.

Authors

  • Dominique J Monlezun
    Department of Cardiology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, United States.
  • Lillian Omutoko
    Department of Educational Management, Policy and Curriculum Studies, University of Nairobi, Nairobi, Kenya.
  • Patience Oduor
    Clinical Trials Unit, University of Global Health Equity, Kigali, Rwanda.
  • Donald Kokonya
    School of Medicine, Masinde Muliro University, Kakamega, Kenya.
  • John Rayel
    College of Science, Bicol University, Legazpi City, Philippines.
  • Claudia Sotomayor
    Pellegrino Center for Clinical Bioethics, Georgetown University, WashingtonDC, USA.
  • Maria Ines Girault
    Faculty of Bioethics, Universidad Anahuac México, Mexico City, Mexico.
  • María Elizabeth De Los Ríos Uriarte
    Faculty of Bioethics, Universidad Anahuac México, Mexico City, Mexico.
  • Oleg Sinyavskiy
    Department of Public Health, Asfendiyarov Kazakh National Medical University, Almaty, Kazakhstan.
  • Timothy Aksamit
    Division of Pulmonary Medicine and Critical Care Medicine, Mayo Clinic, Rochester, USA.
  • Sagar B Dugani
    Hospital Internal Medicine, Mayo Clinic, Rochester, MN, USA.
  • Alberto Garcia
    School of Bioethics, Ateneo Pontificio Regina Apostolorum, Rome, Italy.
  • Colleen Gallagher
    Faculty of Bioethics, Universidad Anahuac México, Mexico City, Mexico.